Hematologic Diseases: all 476 studies
Page 5 of 5. Open to participants first (109), then studies with results posted, then the rest; newest registration first within each.
- Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic DiseasesTerminatedNCT00840567Not applicable
- Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Status unknownNCT00838643
- Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid MalignanciesCompletedNCT00820508Phase 1
- Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia ACompletedNCT00782470
- Intra Bone Marrow Injection Of Unrelated Cord Blood CellsStatus unknownNCT00696046Phase 1/2
- Screening for Subjects to Participate in Studies of Blood DisordersCompletedNCT00695123
- Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron OverloadCompletedNCT00675038
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for BleedingCompletedNCT00616460Phase 3
- Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting SepsisCompletedNCT00561639
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic DisordersCompletedNCT00533923Phase 2
- A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and NeutropeniaWithdrawnNCT00520325Phase 1
- Early Application of CPAP in HematologicCompletedNCT00507533Phase 4
- Functional Evaluation of Two Types of Totally Implanted Venous PortsCompletedNCT00484848Not applicable
- Capillary and Venous Blood Count ParametersCompletedNCT00390988
- Progression of Hematopoietic Diseases in Shanghai, ChinaCompletedNCT00365014
- Molecular Epidemiology of Benzene-exposed Workers.CompletedNCT00364520
- Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCTCompletedNCT00350181Phase 2
- Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl AccidentCompletedNCT00341016
- Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy VolunteersCompletedNCT00223483
- Allogeneic Cell Therapy for Adults With Hematologic MalignanciesCompletedNCT00208962Phase 2
- HLA Matching - Unrelated Umbilical Cord Blood TransplantationCompletedNCT00179946
- Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)CompletedNCT00168090Phase 4
- Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic DiseasesCompletedNCT00137787Phase 3
- SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.CompletedNCT00113893Phase 2
- Treatment and Management of Women With Bleeding DisordersCompletedNCT00111215Not applicable
- Natural History Study for BENCompletedNCT00059423
- Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGCompletedNCT00059293
- Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesCompletedNCT00056966Phase 1/2
- Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IICompletedNCT00037388
- Pain in Sickle Cell Epidemiologic StudyCompletedNCT00035763
- Induction of Stable Chimerism for Sickle Cell AnemiaCompletedNCT00029393Phase 2
- Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaCompletedNCT00029380Phase 2
- Blood and Marrow Transplant Clinical Research NetworkCompletedNCT00023530Not applicable
- Hepatitis C in Clinically Discordant Hemophilic SiblingsCompletedNCT00007371
- Cytomegalovirus Spread and Reactivation in Blood CellsCompletedNCT00006314
- Hemochromatosis--Genetic Prevalence and PenetranceCompletedNCT00006312
- Stroke Prevention in Sickle Cell Anemia (STOP 2)CompletedNCT00006182Phase 3
- Hemostasis in Sickle Cell Disease--Infancy to AdulthoodCompletedNCT00005703
- Aplastic Anemia Epidemiology: Incidence and Case-controlCompletedNCT00005682
- Statistical Basis for Hemochromatosis ScreeningCompletedNCT00005559
- Retention of Bone Marrow Donors in a National RegistryCompletedNCT00005556
- Hemochromatosis and Iron Overload Screening Study (HEIRS)CompletedNCT00005541
- Epidemiology and Immunology of Hemophilia A InhibitorsCompletedNCT00005518
- Indices of Severity and Prognosis for Sickle Cell DiseaseCompletedNCT00005467
- Neuropsychological Studies of Children With Sickle CellCompletedNCT00005438
- Blood Donation--Immune Sequelae and RecruitmentTerminatedNCT00005341
- Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell CenterCompletedNCT00005327
- Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell CenterCompletedNCT00005326
- Prospective Study of HIV Infection in HemophiliacsCompletedNCT00005309
- Anemia and Surgery: Indications For TransfusionCompletedNCT00005308
- Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study DataCompletedNCT00005307
- Hepatitis Delta Infections in HemophiliacsCompletedNCT00005305
- Delta Hepatitis and Liver Disease in HemophiliacsCompletedNCT00005304
- Drug Etiology of Aplastic Anemia and Related DyscrasiasCompletedNCT00005302
- Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell DiseaseCompletedNCT00005300
- Cooperative Study of The Clinical Course of Sickle Cell DiseaseCompletedNCT00005277
- National Health and Nutrition Examination Survey IV (NHANES (IV)CompletedNCT00005154
- Vietnam Era Twin (VET) RegistryCompletedNCT00005126
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Evaluation of Patients With Blood DisordersCompletedNCT00001715
- Evaluation, Treatment, and Training for Patients With Blood DisordersCompletedNCT00001397
- A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast CancerCompletedNCT00001338Phase 3
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)CompletedNCT00000623
- Cord Blood Stem Cell Transplantation Study (COBLT)CompletedNCT00000603Phase 2
- Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)CompletedNCT00000602Phase 2
- Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3
- Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisCompletedNCT00000595Phase 2
- Stroke Prevention in Sickle Cell Anemia (STOP 1)CompletedNCT00000592Phase 3
- Trial to Reduce Alloimmunization to Platelets (TRAP)CompletedNCT00000589Phase 3
- Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl HydrazoneCompletedNCT00000588Phase 2
- Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus InfectionCompletedNCT00000587Phase 2
- Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)CompletedNCT00000586Phase 3
- Penicillin Prophylaxis in Sickle Cell Disease (PROPS)CompletedNCT00000585Phase 3
- Cooperative Study of Factor VIII InhibitorsCompletedNCT00000582Phase 3